Tuberculosis

Scope & Guideline

Fostering collaboration in the realm of immunology and microbiology.

Introduction

Explore the comprehensive scope of Tuberculosis through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Tuberculosis in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN1472-9792
PublisherCHURCHILL LIVINGSTONE
Support Open AccessNo
CountryUnited States
TypeJournal
Converge1974, from 2001 to 2024
AbbreviationTUBERCULOSIS / Tuberculosis
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressJOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND

Aims and Scopes

The journal 'Tuberculosis' focuses on advancing the understanding, diagnosis, treatment, and prevention of tuberculosis (TB) and its causative agent, Mycobacterium tuberculosis. It encompasses a wide range of research areas, from molecular biology to clinical studies, reflecting the complexity of TB as a global health issue.
  1. Pathogenesis and Immunology of Tuberculosis:
    Research on the mechanisms by which Mycobacterium tuberculosis infects the host, evades the immune response, and the resulting immunological responses, including T-cell diversity and macrophage interactions.
  2. Clinical Diagnosis and Biomarkers:
    Studies focused on the development and validation of diagnostic tools and biomarkers for tuberculosis detection, including blood tests, imaging techniques, and molecular assays.
  3. Drug Resistance and Treatment Strategies:
    Exploration of drug-resistant strains of tuberculosis, mechanisms of resistance, and the evaluation of new therapeutic agents and treatment regimens to combat TB.
  4. Epidemiology and Public Health:
    Research on the epidemiological aspects of tuberculosis including transmission patterns, prevalence in different populations, and the impact of TB on public health.
  5. Vaccine Development and Immunization Strategies:
    Investigations into novel vaccines, their efficacy, mechanisms of action, and the role of host immunity in vaccine-induced protection against tuberculosis.
  6. Environmental and Zoonotic Aspects of Mycobacteria:
    Studies exploring non-tuberculous mycobacteria, their environmental reservoirs, and zoonotic transmission dynamics.
The journal has shown a dynamic evolution in its focus, with several emerging themes gaining traction in recent years. These trends reflect the ongoing challenges and advancements in tuberculosis research.
  1. Host-Directed Therapies and Immunotherapy:
    An increasing focus on therapies that enhance the host's immune response to tuberculosis, including novel adjunct therapies and biomarker identification that may guide treatment.
  2. Molecular and Genetic Characterization of Strains:
    A growing emphasis on understanding the genetic diversity and molecular mechanisms of drug resistance in Mycobacterium tuberculosis, facilitating targeted treatment approaches.
  3. Impact of Comorbidities on Tuberculosis:
    Research exploring the interplay between tuberculosis and other conditions, such as diabetes and HIV, is becoming more prevalent, highlighting the need for integrated management strategies.
  4. Advanced Diagnostic Techniques:
    There is a significant trend towards the development of rapid and sensitive diagnostic methods, including genomic and proteomic approaches, which are essential for timely TB detection.
  5. Environmental and Zoonotic Mycobacteria:
    Emerging studies on non-tuberculous mycobacteria and their interactions with human health and the environment are gaining attention, reflecting a broader understanding of mycobacterial diseases.

Declining or Waning

While 'Tuberculosis' continues to cover a vast array of topics, certain themes appear to be declining in frequency or prominence in recent publications. This may reflect shifting research priorities or the maturation of certain areas of study.
  1. Historical Perspectives on Tuberculosis:
    Research focusing on the historical aspects and archaeological findings related to tuberculosis, while still relevant, appears to be less frequent as the journal shifts towards more contemporary issues of TB management and treatment.
  2. Non-Clinical Models of Tuberculosis:
    Studies utilizing animal models or in vitro systems for understanding TB dynamics are becoming less emphasized compared to clinical and epidemiological studies, indicating a potential waning interest in non-human models.
  3. General Microbiology of Mycobacteria:
    While the microbiological aspects of Mycobacterium species remain important, there is a noticeable decrease in non-specific microbiological studies, possibly due to a more targeted focus on tuberculosis-specific research.

Similar Journals

MEDICAL MICROBIOLOGY AND IMMUNOLOGY

Pioneering discoveries in the realms of microbiology and immunology.
Publisher: SPRINGERISSN: 0300-8584Frequency: 6 issues/year

Medical Microbiology and Immunology is a renowned journal published by Springer, serving as a pivotal resource in the fields of microbiology and immunology. Established in 1971 and continuing its legacy through 2024, this journal features cutting-edge research and reviews that address critical advancements and challenges within these dynamic fields. With an impressive impact factor and a robust ranking, including Q1 categories in both Microbiology (medical) and Immunology, it stands at the forefront of scholarly communication, ranking 21st out of 140 in the realm of Medical Microbiology. Researchers and professionals are encouraged to explore a variety of studies that delve into the interactions between microorganisms and the immune system, making it an essential resource for anyone fascinated by these interconnected realms of health sciences. Although not open access, the journal is widely accessible through institutional libraries, ensuring that significant findings reach a global audience. The University of New York Plaza serves as its operational hub in the USA, reinforcing its international influence and dedication to advancing knowledge in microbiology and immunology.

Revista da Sociedade Brasileira de Medicina Tropical

Advancing the frontiers of tropical medicine.
Publisher: SOC BRASILEIRA MEDICINA TROPICALISSN: 0037-8682Frequency: 6 issues/year

Revista da Sociedade Brasileira de Medicina Tropical is a distinguished open-access journal published by the Sociedade Brasileira de Medicina Tropical, focusing on the critical fields of Infectious Diseases, Microbiology, and Parasitology. Since its inception in 1972, this journal has committed to disseminating impactful research that addresses pressing global health challenges, particularly in tropical and infectious diseases prevalent in Brazil and beyond. With a robust publication history, it has been recognized as a Q3 journal in esteemed categories, reflecting its valuable contributions to scientific literature and its ranking in various Scopus categories, including a notable position in Parasitology. Researchers, professionals, and students are encouraged to engage with its rich repository of research, which has been freely accessible since 1997, fostering a wide-reaching impact on public health strategy and scientific innovation.

VIROLOGY

Your Gateway to Cutting-Edge Virology Insights
Publisher: ACADEMIC PRESS INC ELSEVIER SCIENCEISSN: 0042-6822Frequency: 13 issues/year

Virology, published by Academic Press Inc. Elsevier Science, is a prominent journal dedicated to advancing the knowledge and understanding of viral biology and pathogenesis since its inception in 1955. With a distinguished impact factor and recognized as a Q2 journal in the field of Virology for 2023, it ranks 38 out of 80 in the Scopus database for Immunology and Microbiology, placing it in the 53rd percentile among similar publications. This esteemed journal provides a platform for groundbreaking research, critical reviews, and comprehensive studies that contribute to our global understanding of viruses and their impact on health and disease. Although currently not an open-access journal, it remains accessible to a wide audience of researchers, professionals, and students who are keen to explore the latest advancements in virological research. The journal's scope encompasses a diverse range of topics, ensuring that it serves as an essential resource for anyone engaged in virology and related biomedical fields.

COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES

Enhancing Understanding Through Comparative Analyses
Publisher: ELSEVIER SCI LTDISSN: 0147-9571Frequency: 6 issues/year

Comparative Immunology Microbiology and Infectious Diseases, published by Elsevier Science Ltd, is a prominent journal dedicated to advancing the fields of immunology, microbiology, infectious diseases, and veterinary sciences. Established in 1978, this journal has become a vital resource for researchers and professionals alike, with a commendable impact factor that reflects its significance in academia. The journal, available in both print and electronic formats (ISSN: 0147-9571, E-ISSN: 1878-1667), stands out for its commitment to disseminating innovative research findings, particularly through its categorization in Q2 and Q3 quartiles across various related disciplines as of 2023. The journal aims to provide insightful comparative analyses that enhance our understanding of host-pathogen interactions, immune responses, and disease manifestations. With a global readership base, it serves as a platform for collaborative discourse among scientists and professionals, ultimately contributing to the improvement of health outcomes worldwide.

MICROBES AND INFECTION

Fostering Global Collaboration in Microbiology
Publisher: ELSEVIERISSN: 1286-4579Frequency: 12 issues/year

MICROBES AND INFECTION is a premier academic journal published by Elsevier, dedicated to the dynamic fields of immunology, infectious diseases, and microbiology. With a notable impact factor reflective of its high-quality research contributions, the journal is categorized in the Q2 quartile across these fields as of 2023. Based in France and operating since 1999, MICROBES AND INFECTION offers a platform for researchers, professionals, and students to disseminate and access cutting-edge findings that drive innovation and knowledge in microbial and infectious disease research. The journal is ranked impressively within the Scopus database, securing ranks such as #16 in Microbiology and #33 in Infectious Diseases, underscoring its high relevance in the scientific community. Subscribers to the journal can expect an array of articles, reviews, and original research, all designed to advance understanding and improve clinical practices in the fight against infectious agents. With its ongoing commitment to open access options, MICROBES AND INFECTION continues to foster global collaboration and information sharing in the pursuit of addressing pressing microbiological challenges.

JAPANESE JOURNAL OF INFECTIOUS DISEASES

Empowering professionals with cutting-edge research and discoveries.
Publisher: NATL INST INFECTIOUS DISEASESISSN: 1344-6304Frequency: 6 issues/year

The Japanese Journal of Infectious Diseases, published by the National Institute of Infectious Diseases in Japan, serves as a vital platform for researchers, clinicians, and public health professionals committed to advancing the field of infectious disease science. With an ISSN of 1344-6304 and an E-ISSN of 1884-2836, this journal has maintained its academic rigor since its inception in 1961 and continues to contribute significantly to the global understanding of infectious diseases. The journal holds a Q3 ranking in the categories of Infectious Diseases, Miscellaneous Medicine, and Medical Microbiology as of 2023, reflecting its important role in disseminating impactful research. With many articles available through Open Access, it ensures wide accessibility to the latest discoveries and insights. Researchers can expect to find high-quality studies that address critical challenges in the control and prevention of infectious diseases, making this journal an essential resource for anyone engaging in this critical field.

INFECTION GENETICS AND EVOLUTION

Advancing the Frontiers of Infection and Evolution
Publisher: ELSEVIERISSN: 1567-1348Frequency: 8 issues/year

INFECTION GENETICS AND EVOLUTION is a premier scholarly journal published by Elsevier, focusing on the dynamic field of infection genetics and evolutionary biology. Since its inception in 2001, this journal has emerged as a critical platform for the dissemination of cutting-edge research, bridging the gap between molecular genetics, evolutionary theory, and infectious disease study. With an influence profound enough to secure its status in the Q1 category for Ecology, Evolution, Behavior and Systematics and impressive Q2 rankings in Genetics, Infectious Diseases, and Microbiology, the journal offers researchers unparalleled insights that advance the understanding of pathogen evolution and host interactions. Despite the lack of Open Access, the research published in this journal significantly contributes to the academic discourse and informs public health approaches. By publishing high-quality studies and reviews through 2024, INFECTION GENETICS AND EVOLUTION remains indispensable for academics, professionals, and students seeking to explore the intricate mechanisms of infection and adaptation in various organisms.

INTERVIROLOGY

Advancing virology through innovative research.
Publisher: KARGERISSN: 0300-5526Frequency: 6 issues/year

INTERVIROLOGY is a leading academic journal dedicated to advancing the field of virology and infectious diseases, published by KARGER. With a commendable history since its inception in 1973, the journal is currently poised to explore innovative virological research through to 2024. INTERVIROLOGY is indexed with the ISSN 0300-5526 and E-ISSN 1423-0100, reflecting its commitment to maintaining high scholarly standards. The journal is categorized within the Q3 quartile for both Infectious Diseases and Virology as of 2023, demonstrating its relevance and contribution to the academic community. With Scopus rankings placing it as #130 in Infectious Diseases and #41 in Virology, INTERVIROLOGY serves as an essential resource for researchers, professionals, and students seeking cutting-edge insights and discoveries in virology. While it currently operates under a subscription model, its rigorous peer-review process ensures a high quality of published content, making it a cornerstone for those dedicated to understanding and combating viral diseases.

EPIDEMIOLOGIE MIKROBIOLOGIE IMUNOLOGIE

Advancing Knowledge in Health Sciences
Publisher: CESKA LEKARSKA SPOLECNOST J EV PURKYNEISSN: 1210-7913Frequency: 4 issues/year

EPIDEMIOLOGIE MIKROBIOLOGIE IMUNOLOGIE is a prominent scholarly journal published by CESKA LEKARSKA SPOLECNOST J EV PURKYNE in the Czech Republic. With an ISSN of 1210-7913, this journal has been at the forefront of research since its inception in 1994, showcasing a rich repository of studies bridging the domains of epidemiology, microbiology, immunology, and infectious diseases, and reflecting advancements over three decades. Although it currently falls within the Q4 category in multiple fields including Epidemiology and Microbiology, the journal serves an essential role in disseminating knowledge and fostering discussions around public health challenges. The contributions made through its pages are vital for researchers, healthcare professionals, and students aiming to enhance their understanding of complex biomedical issues. While it does not offer open access, the journal remains a critical resource in its niches, inviting readers to engage with the latest findings and methodologies reshaping the landscape of health science.

Microbiology Spectrum

Fostering collaboration through open access innovation.
Publisher: AMER SOC MICROBIOLOGYISSN: 2165-0497Frequency: 6 issues/year

Microbiology Spectrum is a prominent peer-reviewed journal published by the American Society for Microbiology, dedicated to advancing the field of microbiology through the dissemination of high-quality research. Since its inception in 2013 and continuing until 2024, the journal has established a strong presence in key domains such as microbiology, immunology, cell biology, and ecology, achieving impressive quartile rankings including Q1 in Infectious Diseases and Q1 in Immunology and Microbiology as of 2023. With an emphasis on open access to its scholarly content, Microbiology Spectrum aims to foster collaboration and knowledge sharing among researchers, professionals, and students alike. The journal's scope encompasses a diverse range of topics pertinent to the field, making it an essential resource for anyone involved in microbiological research and its applications. Researchers looking to publish their findings in a respected journal will find Microbiology Spectrum's robust impact factor and Scopus rankings serve as testament to its significance and influence within the academic community.